Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN

Clinical trial NCT04857957 · COMPLETED

Trial details

NCT number: NCT04857957
Sponsor: Centrexion Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Painful Diabetic Neuropathy

Start date: 2021-04-14
Primary completion: 2023-08-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.